Type 2 diabetes trials in Spain

In Spain 56 Also abroad 1196

56 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
A Coruna, Barcelona, Castilleja De La Cuesta, Madrid, Pamplona, Santander, Sevilla, Valencia
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
A Coruña, Badalona, Barcelona, Ferrol, Madrid, Málaga, Pozuelo de Alarcón, Sevilla
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
No phaseTaking people
Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
Where
Madrid, Zaragoza
People
60 worldwide
Run by
Sanofi
See details and how to joinNCT07457580
Phase 3Taking people
AMBITION 3: A research study investigating how well zenagamtide at higher dose levels lowers blood sugar and body weight compared to semaglutide in people with type 2 diabetes treated with metformin, SGLT2i, or both
Where
Almería, Barcelona, Cabra, Castilleja De La Cuesta, Pozuelo de Alarcón, San Cugat del Vallés, Santa Cruz de Tenerife, Santander, Vic
Age
18 years and over
People
595 worldwide
Run by
Novo Nordisk A/S
See details and how to join2026-525472-26-00 · EU 2026-525472-26-00
Phase 3Taking people
AMBITION 4: A research study investigating how well zenagamtide at lower dose levels lowers blood sugar and body weight compared to semaglutide at lower dose levels in people with type 2 diabetes treated with metformin, SGLT2i, or both
Where
Barcelona, Girona, L'Hospitalet de Llobregat (Barcelona), Monzón, Salamanca, Sevilla
Age
18 years and over
People
245 worldwide
Run by
Novo Nordisk A/S
See details and how to join2026-525474-20-00 · EU 2026-525474-20-00
Phase 3Taking people
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Where
A Coruna, Madrid, Pozuelo de Alarcón, Sevilla
Age
18 years and over
People
954 worldwide
Run by
Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00
Phase 3Taking people
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Where
Barcelona, Málaga, Sevilla
Age
10 years to 17 years
People
170 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07668336 · EU 2025-524811-35-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Where
Alzira, Barcelona, Castilleja De La Cuesta, Madrid, Málaga, Sevilla, Centro Médico Compostela
Age
18 years and over
People
1,035 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Where
A Coruna, Almería, Barcelona, Castilleja De La Cuesta, Ferrol, Palma, Pozuelo de Alarcón, Santander, Sevilla
Age
18 years and over
People
900 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00
Phase 3Taking people
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Where
A Coruña, Alzira, Barcelona, Ferrol, Granada, Málaga, Seville
Age
18 years and over
People
1,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00
Phase 3Not yet taking people in Spain
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
A Coruña, Alzira, Castilleja De La Cuesta, Ferrol, Granada, Lugo, Madrid, Majadahonda, Palma, Pozuelo de Alarcón, Santander, Sevilla, Valencia
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
Phase 3Taking people
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Where
Badalona, Barcelona, Córdoba, Galdakao, Granada, Huelva, Jaén, Las Palmas De Gran Canaria, Madrid, Sabadell, Santander, Sevilla, Toledo, Valencia, Valladolid, Vigo, Villamartín
Age
18 years and over
People
11,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Where
A Coruña, Alzira (Valencia), Barcelona, Castilleja de La Cuesta, Sevilla, Ferrol (A Coruña), Lleida, Málaga, Oviedo, Segovia, Seville
Age
18 years and over
People
1,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784270
No phaseTaking people
Dietitian-Nutritionist vs. Day Hospital in the Metabolic Control of Patients With Type 2 Diabetes
Where
Vilafranca del Penedès
Age
18 years and over
People
140
Run by
Consorci Sanitari de l'Alt Penedès i Garraf
See details and how to joinNCT07285330
No phaseTaking people
Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus
Where
Elche
Age
40 years to 69 years
People
80
Run by
Cardenal Herrera University
See details and how to joinNCT07373938
No phaseTaking people
An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk Score
Where
Many Locations
Age
18 years and over
People
500
Run by
Bayer
See details and how to joinNCT07554469
Phase 3Taking people
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
A Coruña, Almería, Badalona, Barcelona, León, Madrid, Santander, Santiago de Compostela, Seville, Tarragona, Valencia
Age
18 years and over
People
4,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803
Phase 3Taking people
A Study to evaluate effect of AZD6234 in adult participants with Type 2 Diabetes Mellitus and obesity or overweight
Where
A Coruña, Alzira, Barcelona, Castilleja De La Cuesta, Ferrol, Lleida, Málaga, Oviedo, Segovia, Sevilla
Age
18 years and over
People
420 worldwide
Run by
AstraZeneca AB
See details and how to join2025-524616-11-00 · EU 2025-524616-11-00
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Where
Barcelona, Centelles, Madrid, Santander, Sevilla, Vic
Age
18 years to 75 years
People
300 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07668388 · EU 2026-525465-42-00
Phase 3Not yet taking people in Spain
Impact of Semaglutide in Liver Transplant Candidates with Obesity (SOMAL Study): A Prospective Randomized Study.
Where
Murcia
Age
18 years and over
People
50
Run by
Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
See details and how to join2026-526953-32-00 · EU 2026-526953-32-00
Phase 3Taking people
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
A Coruña, Antequera, Barcelona, Centelles, Fuenlabrada, Girona, Madrid, Málaga, Manresa, Valladolid
Age
18 years and over
People
2,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00
No phaseTaking people
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
Where
Barcelona
Age
18 years to 99 years
People
24,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT05663515
No phaseTaking people
Involvement of Muscle Mitochondrial Dysfunction in Frailty in Older Adults. Role of Exercise
Where
Valencia
Age
18 years to 83 years
People
120
Run by
Fundación para la Investigación del Hospital Clínico de Valencia
See details and how to joinNCT07828847
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Where
A Estrada, Barcelona, Castilleja De La Cuesta, Girona, Santiago de Compostela
Age
18 years to 75 years
People
270 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07415954 · EU 2025-523260-20-00
Phase 3Taking people
A trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes
Where
A Coruna, Almería, Badalona, Barcelona, Castilleja De La Cuesta, León, Madrid, Santander, Santiago de Compostela, Sevilla, Tarragona, Valencia
Age
18 years and over
People
1,010 worldwide
Run by
AstraZeneca AB
See details and how to join2025-524688-19-00 · EU 2025-524688-19-00